Company Profile

AvidBiotics Corporation
Profile last edited on: 5/29/2019      CAGE: 37JR5      UEI: M4LZBC3MYL59

Business Identifier: Protein therapeutics for bacterial diseases
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

100 Kimball Way
South San Francisco, CA 94080
   (650) 873-1234
Location: Single
Congr. District: 15
County: San Mateo

Public Profile

AvidBiotics Corporation is a biotechnology company developing non-antibody proteins as targeted therapeutics, The firm has two proprietary product platforms. One: a new class of tailorable, targeted bactericidal agents for use in the treatment or prevention of specific bacterial infections or contaminations. Two: a technology platform specifically flags virus-infected or cancerous cells for enhanced destruction by the Natural Killer and T-cells of the potent innate immunity system. AvidBiotics focuses on human therapeutic applications of its technologies, both on its own and in partnership with governmental agencies and research institutions, while taking advantage of further near-term collaborative opportunities offered by specific applications of its products and technology platforms in areas such as food safety, biodefense and animal husbandry. Headed up by a highly experienced biotech industry players, the firm has important collaborations with two major corporations.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Key People / Management

  James Knighton -- President and Director

  David (William) Martin -- Founder, Chief Executive Officer and Director

  Jeffery F Miller -- Co-Founder, Chairman of Scientific Advisory Board and Director

  Dean M Scholl